Question 1

How does Rauwolfia serpentina lower blood pressure?

Accepted Answer

Rauwolfia serpentina lowers blood pressure by depleting catecholamines—norepinephrine, dopamine, and serotonin—from nerve terminals and storage sites. The primary alkaloid, reserpine, irreversibly inhibits the vesicular monoamine transporter (VMAT), preventing neurotransmitter storage in synaptic vesicles. This leads to gradual degradation of these compounds and sustained reduction in sympathetic nervous system activity. The result is decreased peripheral vascular resistance, reduced heart rate, and lowered blood pressure. This same mechanism produces sedative effects on the central nervous system. Evidence Level: C (traditional use with established pharmacological mechanism).

Question 2

Can I take Rauwolfia with MAO inhibitors?

Accepted Answer

No, Rauwolfia should never be combined with MAO inhibitors. This combination is contraindicated due to the risk of severe hypotension and excessive CNS depression. Both substances affect monoamine neurotransmitters through different mechanisms—Rauwolfia depletes stored catecholamines while MAO inhibitors prevent their breakdown—creating unpredictable and potentially dangerous effects. Additional interactions occur with other antihypertensives (additive blood pressure lowering), digitalis, quinidine, and CNS depressants including alcohol and barbiturates. Patients on antidepressants should avoid Rauwolfia entirely. Medical supervision is essential for anyone considering this herb.

Question 3

What is the recommended dosage of Rauwolfia root?

Accepted Answer

Rauwolfia should only be used in standardized pharmaceutical preparations under medical supervision due to its narrow therapeutic index. Traditional adult dosages range from 50-300mg of crude drug daily, equivalent to approximately 0.1-0.5mg of reserpine. However, self-medication is strongly discouraged. Dosage must be individualized based on patient condition, age, and response. In Ayurvedic practice, the root is processed into specific formulations. Modern clinical use has largely been replaced by safer antihypertensive medications. Evidence Level: C. Always consult a qualified healthcare provider before use.

Question 4

Is Rauwolfia safe during pregnancy and breastfeeding?

Accepted Answer

Rauwolfia serpentina is contraindicated during pregnancy and breastfeeding—it is considered unsafe. Reserpine crosses the placenta and may cause fetal harm, including neonatal respiratory depression and bradycardia. The herb can stimulate uterine contractions, potentially inducing miscarriage or premature labor. Catecholamine depletion poses cardiovascular risks to both mother and fetus. Reserpine is excreted in breast milk and can cause nasal congestion, lethargy, and poor feeding in nursing infants. Pregnant individuals with hypertension should work with their healthcare provider to identify safer alternatives. This herb should be strictly avoided throughout pregnancy and lactation.

Question 5

Why does Rauwolfia cause depression as a side effect?

Accepted Answer

Rauwolfia causes depression through its mechanism of depleting monoamine neurotransmitters, particularly norepinephrine, dopamine, and serotonin in the brain. These neurotransmitters are essential for mood regulation, motivation, and emotional stability. When reserpine irreversibly inhibits VMAT, these compounds cannot be stored and are gradually degraded, leading to significant depletion over time. The resulting neurotransmitter deficiency can produce severe depression, sometimes progressing to suicidal ideation. This is why Rauwolfia is contraindicated in patients with any history of depression or psychiatric disorders. The effect may persist for weeks after discontinuation due to the irreversible nature of reserpine binding.

Rauwolfia Root

Sources et citations

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Synthèse des preuves

Sources PubMed

Sources gouvernementales